Bookbuilding IPO | ₹34 Cr | Listed at NSE SME | Tue, Sep 30, 2025 - Fri, Oct 3, 2025
Sheel Biotech IPO is a book build issue of ₹34.02 crores. The issue is entirely a fresh issue of 0.54 crore shares of ₹34.02 crore.
Sheel Biotech IPO bidding started from Sep 30, 2025 and ended on Oct 3, 2025. The allotment for Sheel Biotech IPO was finalized on Oct 6, 2025. The shares got listed on NSE SME on Oct 8, 2025.
Sheel Biotech IPO price band is set at ₹63 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹2,52,000 (4,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (6,000 shares), amounting to ₹3,78,000.
Narnolia Financial Services Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Mansi Share & Stock Broking Pvt.Ltd..
Refer to Sheel Biotech IPO RHP for detailed Information.
IPO Open
Tue, Sep 30, 2025
IPO Close
Fri, Oct 3, 2025
Issue Price
₹63 per share
Market Cap (Pre-IPO)
₹128.22 Cr
| IPO Date | 30 Sep to 3 Oct, 2025 |
| Listed on | Wed, Oct 8, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹59 to ₹63 |
| Issue Price | ₹63 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 54,00,000 shares (agg. up to ₹34 Cr) |
| Reserved for Market Maker | 2,72,000 shares Mansi Share & Stock Broking Pvt.Ltd. (agg. up to ₹2 Cr) |
| Fresh Issue (Ex Market Maker) | 51,28,000 shares (agg. up to ₹32 Cr) |
| Net Offered to Public | 51,28,000 shares (agg. up to ₹32 Cr) |
| Share Holding Pre Issue | 1,49,52,550 shares |
| Share Holding Post Issue | 2,03,52,550 shares |
| NSE Symbol | SHEEL |
| ISIN | INE0YJV01017 |
Sheel Biotech IPO comprises a total issue size of 54,00,000 shares. The net offer to the public is 51,28,000 shares, after excluding 2,72,000 shares allotted on a firm basis. Of the Net offer 25,50,000 (49.73%) are allocated to QIB, 7,74,000 (15.09%) allocated to NII 18,04,000 (35.18%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| QIB Shares Offered | 25,50,000 | 49.73% | 47.22% |
| − Anchor Investor Shares Offered | 15,24,000 | 28.22% | |
| − QIB (Ex. Anchor) Shares Offered | 10,26,000 | 19.00% | |
| NII (HNI) Shares Offered | 7,74,000 | 15.09% | 14.33% |
| − bNII > ₹10L | 5,16,000 | 9.56% | |
| − sNII < ₹10L | 2,58,000 | 4.78% | |
| Retail Shares Offered | 18,04,000 | 35.18% | 33.41% |
| Firm Reservations | |||
| Market Maker Shares Offered | 2,72,000 | 5.04% | |
| Total Shares Offered | 54,00,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,52,000 |
| Individual investors (Retail) (Max) | 2 | 4,000 | ₹2,52,000 |
| S-HNI (Min) | 3 | 6,000 | ₹3,78,000 |
| S-HNI (Max) | 7 | 14,000 | ₹8,82,000 |
| B-HNI (Min) | 8 | 16,000 | ₹10,08,000 |
Sheel Biotech IPO raises ₹9.60 crore from anchor investors. Sheel Biotech IPO Anchor bid date is September 29, 2025.
📝 Anchor Investors Letter (PDF)
| Bid Date | Mon, Sep 29, 2025 |
| Shares Offered | 15,24,000 |
| Anchor Portion (₹ Cr.) | 9.60 |
| Anchor lock-in period end date for 50% shares (30 Days) | Wed, Nov 5, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | Sun, Jan 4, 2026 |
Incorporated in November 1991, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.
The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming.
The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs.
They also deliver landscaping services to the government and private sectors.
The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications, reflecting its commitment to quality, environmental responsibility, and safety.
The company's Research and Development laboratory is recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) of the Government of India.
Sheel Biotech offers a diverse range of services and products, including:
As of September 12, 2025, the Company has 160 permanent employees on its payroll.
Competitive Strength:
Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 113.28 | 105.95 | 93.89 |
| Total Income | 102.27 | 92.55 | 80.19 |
| Profit After Tax | 10.64 | 10.47 | 5.08 |
| EBITDA | 14.97 | 14.45 | 8.83 |
| NET Worth | 83.85 | 72.69 | 63.54 |
| Reserves and Surplus | 68.90 | 68.58 | 59.40 |
| Total Borrowing | 17.36 | 23.54 | 19.17 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure Requirement | 9.12 |
| 2 | Working Capital Requirement | 15.88 |
| 3 | General Corporate Purposes | 4.77 |
| 4 | Issue Expense | 4.25 |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 13.59% |
| ROCE | 16.34% |
| Debt/Equity | 0.21 |
| RoNW | 13.59% |
| PAT Margin | 10.45% |
| EBITDA Margin | 14.71% |
| Price to Book Value | 1.11 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 7.11 | 5.23 |
| P/E (x) | 8.86 | 12.06 |
| Promoter Holding | 96.99% | 71.26% |
| Market Cap | ₹128.22 Cr. |
The Sheel Biotech IPO is subscribed 15.97 times on October 3, 2025 6:19:16 PM (Day 3). The public issue subscribed 9.56 times in the individual investors category, 19.73 times in the QIB category, and 25.92 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for | Total Application |
|---|---|---|---|---|
| QIB (Ex Anchor) | 19.73 | 10,26,000 | 2,02,44,000 | 18 |
| NII* | 25.92 | 7,74,000 | 2,00,62,000 | 1,360 |
| bNII (bids above ₹10L) | 31.64 | 5,16,000 | 1,63,24,000 | |
| sNII (bids below ₹10L) | 14.49 | 2,58,000 | 37,38,000 | |
| Individual Investor | 9.56 | 18,04,000 | 1,72,40,000 | 4,310 |
| Total | 15.97 | 36,04,000 | 5,75,46,000 | 5,688 |
Total Application : 5,688
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead manager(s) fees including underwriting commission. | 2.00 |
| 2 | Brokerage, selling commission and upload fees | 0.01 |
| 3 | Registrars to the issue | 0.01 |
| 4 | Legal Advisors | 0.02 |
| 5 | Peer Review Auditor fees | 0.03 |
| 6 | Printing, Advertising and marketing expenses | 0.06 |
| 7 | Regulators including stock exchanges | 0.10 |
| 8 | Others, if any (Market Maker fees, Selling and Distribution Expenses, Marketing Expenses and other misc. expenses) | 2.03 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹63.00 |
| Open | ₹91.00 |
| Low | ₹91.00 |
| High | ₹95.55 |
| Last Trade | ₹95.55 |
Lead Manager Reports
Sheel Biotech IPO is a SME IPO of 54,00,000 equity shares of the face value of ₹10 aggregating up to ₹34 Crores. The issue is priced at ₹63 per share. The minimum order quantity is 2000.
The IPO opens on Tue, Sep 30, 2025, and closes on Fri, Oct 3, 2025.
Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sheel Biotech IPO using UPI as a payment gateway. Zerodha customers can apply in Sheel Biotech IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sheel Biotech IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sheel Biotech IPO opens on Tue, Sep 30, 2025 and closes on Fri, Oct 3, 2025.
Sheel Biotech IPO lot size is 2000, and the minimum amount required for application is ₹2,52,000, with 2 lots being the minimum application size.
You can apply in Sheel Biotech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Sheel Biotech IPO will be done on Monday, October 6, 2025, and the allotted shares will be credited to your demat account by Tue, Oct 7, 2025. Check the Sheel Biotech IPO allotment status.
The Sheel Biotech IPO listing date is on Wed, Oct 8, 2025.
